Literature DB >> 30122423

iPSC-Derived Cardiomyocytes Taken to Rescue Infarcted Heart Muscle in Coronary Heart Disease Patients.

Seppo Ylä-Herttuala1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30122423      PMCID： PMC6127967          DOI： 10.1016/j.ymthe.2018.08.006

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  2 in total

1.  'Reprogrammed' stem cells approved to mend human hearts for the first time.

Authors:  David Cyranoski
Journal:  Nature       Date:  2018-05       Impact factor: 49.962

2.  Temporal Dynamics of Gene Expression During Endothelial Cell Differentiation From Human iPS Cells: A Comparison Study of Signalling Factors and Small Molecules.

Authors:  Heini Belt; Jonna K Koponen; Tuija Kekarainen; Katja A Puttonen; Petri I Mäkinen; Henri Niskanen; Joni Oja; Galina Wirth; Jari Koistinaho; Minna U Kaikkonen; Seppo Ylä-Herttuala
Journal:  Front Cardiovasc Med       Date:  2018-03-14
  2 in total
  1 in total

1.  Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study.

Authors:  Adrian J C Bloor; Amit Patel; James E Griffin; Maria H Gilleece; Rohini Radia; David T Yeung; Diana Drier; Laurie S Larson; Gene I Uenishi; Derek Hei; Kilian Kelly; Igor Slukvin; John E J Rasko
Journal:  Nat Med       Date:  2020-09-14       Impact factor: 53.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.